Inotuzumab ozogamicin for the treatment of patients with acute lymphocytic leukemia

Choudhry, A; O'Brien, SM

Choudhry, A (reprint author), Univ Calif Irvine Hlth, Dept Med, Div Hematol & Med Oncol, 101 City Dr South, Orange, CA 92868 USA.

DRUGS OF TODAY, 2017; 53 (12): 653

Abstract

Inotuzumab ozogamicin is an antibody-drug conjugate comprised of a humanized anti-CD22 monoclonal antibody conjugated to calicheamicin, a cytotoxic an......

Full Text Link